thiazolyl blue has been researched along with Macular Degeneration in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dithmer, M; Fuchs, S; Klettner, A; Richert, E; Roider, J; Schmidt, H; Shi, Y | 1 |
Jia, H; Jia, X; Li, X; Liu, J; Liu, Z; Long, J; Sun, L; Wang, Y; Weber, P; Zhu, L | 1 |
2 other study(ies) available for thiazolyl blue and Macular Degeneration
Article | Year |
---|---|
Fucoidan reduces secretion and expression of vascular endothelial growth factor in the retinal pigment epithelium and reduces angiogenesis in vitro.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line; Collagen; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Immunohistochemistry; Laminin; Macular Degeneration; Microscopy, Confocal; Neovascularization, Physiologic; Polysaccharides; Proteoglycans; Retinal Pigment Epithelium; Tetrazolium Salts; Thiazoles; Trypan Blue; Vascular Endothelial Growth Factor A | 2014 |
Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction.
Topics: Acrolein; Antioxidants; Calcium; Cell Line; Cell Survival; Coloring Agents; DNA Damage; Glutathione; Glutathione Transferase; Humans; Indicators and Reagents; Macular Degeneration; Mitochondria; Neuroprotective Agents; NF-E2-Related Factor 1; Oxidants; Oxidative Stress; Phenylethyl Alcohol; Protein Carbonylation; Retinal Pigment Epithelium; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2007 |